KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $246.2 million.

  • Medpace Holdings' Cash from Operations rose 6515.78% to $246.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $711.2 million, marking a year-over-year increase of 2379.16%. This contributed to the annual value of $608.8 million for FY2024, which is 4048.26% up from last year.
  • Latest data reveals that Medpace Holdings reported Cash from Operations of $246.2 million as of Q3 2025, which was up 6515.78% from $148.5 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Cash from Operations ranged from a high of $246.2 million in Q3 2025 and a low of $46.3 million during Q1 2022
  • In the last 5 years, Medpace Holdings' Cash from Operations had a median value of $114.4 million in 2023 and averaged $116.5 million.
  • In the last 5 years, Medpace Holdings' Cash from Operations plummeted by 3280.06% in 2021 and then soared by 9280.05% in 2022.
  • Medpace Holdings' Cash from Operations (Quarter) stood at $70.9 million in 2021, then surged by 92.8% to $136.7 million in 2022, then increased by 14.42% to $156.4 million in 2023, then grew by 21.91% to $190.7 million in 2024, then grew by 29.13% to $246.2 million in 2025.
  • Its Cash from Operations was $246.2 million in Q3 2025, compared to $148.5 million in Q2 2025 and $125.8 million in Q1 2025.